The karyotype marked A — 46,XX/47,XX,+16 — represents confined placental mosaicism (CPM) for trisomy 16. The critical clinical finding is that CVS shows mosaic trisomy 16 in cytotrophoblast cells, but the follow-up amniocentesis reveals a normal 46,XX fetal karyotype. This dissociation defines CPM: the chromosomal abnormality is present in the placenta (derived from trophoblast) but absent from the fetus (derived from epiblast). Trisomy 16 is the most common autosomal trisomy at conception (~1% of pregnancies) but is universally lethal in non-mosaic form; most miscarry in the first trimester. When trisomy 16 arises post-zygotically and is then selectively lost from the fetal cell line via trisomy rescue, the pregnancy can continue, but the surviving placenta retains trisomic cells. This impairs placental function, causing the observed IUGR, oligohydramnios, and increased risk of stillbirth and preeclampsia. The normal amniocentesis is reassuring for the fetus, but uniparental disomy (UPD) for chromosome 16 must be excluded — trisomy rescue can leave the fetus with two copies from one parent, and maternal UPD16 is associated with IUGR even with a disomic karyotype. (Williams Obstetrics 26e, Prenatal Diagnosis chapter)
Williams Obstetrics 26e — Prenatal Diagnosis
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.